Analysts’ Upgrades for March 29th (ABOS, ALK, APVO, ASMB, ATAT, AVTX, BKV, CABA, CNMD, ECO)

Analysts’ upgrades for Sunday, March 29th:

Acumen Pharmaceuticals (NASDAQ:ABOS) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Alaska Air Group (NYSE:ALK) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Aptevo Therapeutics (NASDAQ:APVO) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Assembly Biosciences (NASDAQ:ASMB) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Atour Lifestyle (NASDAQ:ATAT) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Avalo Therapeutics (NASDAQ:AVTX) was upgraded by analysts at Wall Street Zen from a strong sell rating to a hold rating.

BKV (NYSE:BKV) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Cabaletta Bio (NASDAQ:CABA) was upgraded by analysts at Wall Street Zen from a strong sell rating to a hold rating.

CONMED (NYSE:CNMD) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Okeanis Eco Tankers (NYSE:ECO) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Enphase Energy (NASDAQ:ENPH) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Escalade (NASDAQ:ESCA) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

First Northwest Bancorp (NASDAQ:FNWB) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

H. B. Fuller (NYSE:FUL) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Gen Digital (NASDAQ:GEN) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Global-e Online (NASDAQ:GLBE) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Gates Industrial (NYSE:GTES) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Healthcare Services Group (NASDAQ:HCSG) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

HYNE (NASDAQ:HYNE) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Lument Finance Trust (NYSE:LFT) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Lsb Industries (NYSE:LXU) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Massimo Group (NASDAQ:MAMO) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

MetroCity Bankshares (NASDAQ:MCBS) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Dave & Buster’s Entertainment (NASDAQ:PLAY) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Quad Graphics (NYSE:QUAD) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Runway Growth Finance (NASDAQ:RWAY) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Redwood Trust (NYSE:RWT) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Smithfield Foods (NASDAQ:SFD) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at Wall Street Zen from a hold rating to a strong-buy rating.

Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at Wall Street Zen from a hold rating to a strong-buy rating.

Tejon Ranch (NYSE:TRC) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Trinity Capital (NASDAQ:TRIN) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Victory Capital (NASDAQ:VCTR) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Receive News & Ratings for Acumen Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acumen Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.